✦ LIBER ✦

Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancer

✍ Scribed by Michael J. Duffy; David Reilly; E. McDermott; Niall O'Higgins; James J. Fennelly; Peter A. Andreasen

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 357 KB
Volume: 74
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19941015)74:8<2276::aid-cncr2820740811>3.0.co;2-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Urokinase plasminogen activator: A progn

Urokinase plasminogen activator: A prognostic marker in multiple types of cancer

✍ Duffy, Michael J.; Maguire, Teresa M.; McDermott, Enda W.; O'Higgins, Niall 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

Urokinase plasminogen activator (uPA) is a serine protease causally involved in cancer invasion and metastasis. Consistent with its role in cancer spread, uPA has been shown to be a prognostic marker in a variety of malignancies, especially breast cancer. Approximately 20 different groups have shown

High level of urokinase-type plasminogen

High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma

✍ Jae Yong Cho; Hyun Cheol Chung; Sung Hoon Noh; Jae Kyung Roh; Jin Sik Min; Byung 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

defined risk factor in patients with gastric carcinoma. ## METHODS. Enzyme-linked immunoadsorbent assays were used to test for uPA anti-

Evaluation of a displacement assay with

Evaluation of a displacement assay with tamoxifen as prognostic indicator in breast-cancer patients with estrogen-receptor-positive tumors

✍ Emanuel Levin; Andrea M. Actis; Silvana Caruso; Hugo Gass; Raquel Romero; Nicolá 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 95 KB 👁 1 views

A displacement assay with tamoxifen, based on the relative binding affinity of tamoxifen and estradiol for the estrogen receptor (ER), was proposed in 1990 as prognostic indicator for breast-cancer patients. Validation of its predictive results in relation to the outcome of 73 patients with ER ؉ tum

Inability of bone turnover marker as a s

Inability of bone turnover marker as a strong prognostic indicator in prostate cancer patients with bone metastasis: Comparison with the extent of disease (EOD) grade

✍ Akimoto, Susumu; Furuya, Yuzo; Akakura, Koichiro; Shimazaki, Jun; Ito, Haruo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

## Background: Although clinical investigations of bone turnover markers in prostate cancer patients have been conducted, the relationships of pretreatment levels of the markers to the prognosis of patients with bone metastasis has not been fully examined. ## Methods: The serum levels of carboxy-